216eP MegaMOST - A multicenter, open-label, molecularly selected bayesian phase II platform trial in advanced or metastatic solid tumors: Final analysis of the trametinib cohort.
Saved in:
| Title: | 216eP MegaMOST - A multicenter, open-label, molecularly selected bayesian phase II platform trial in advanced or metastatic solid tumors: Final analysis of the trametinib cohort. |
|---|---|
| Authors: | Tredan, O.1 (AUTHOR), Saada, E.B.2 (AUTHOR), Dalban, C.3 (AUTHOR), Cousin, S.4 (AUTHOR), Le Cesne, A.5 (AUTHOR), Italiano, A.6 (AUTHOR), Bertucci, F.7 (AUTHOR), Gomez-Roca, C.A.8 (AUTHOR), Eberst, L.9 (AUTHOR), Ray-Coquard, I.L.10 (AUTHOR), Verlingue, L.11 (AUTHOR), Cassier, P.12 (AUTHOR), Attignon, V.K.13 (AUTHOR), Chabaud, S.14 (AUTHOR), Mayet, R.15 (AUTHOR), Cauquil, E.16 (AUTHOR), Fournier Garin, G.3 (AUTHOR), Perol, D.17 (AUTHOR), Blay, J-Y.18 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS291-S292. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189418493 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 216eP MegaMOST - A multicenter, open-label, molecularly selected bayesian phase II platform trial in advanced or metastatic solid tumors: Final analysis of the trametinib cohort. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Tredan%2C+O%2E%22">Tredan, O.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saada%2C+E%2EB%2E%22">Saada, E.B.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dalban%2C+C%2E%22">Dalban, C.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cousin%2C+S%2E%22">Cousin, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Le+Cesne%2C+A%2E%22">Le Cesne, A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Italiano%2C+A%2E%22">Italiano, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bertucci%2C+F%2E%22">Bertucci, F.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gomez-Roca%2C+C%2EA%2E%22">Gomez-Roca, C.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eberst%2C+L%2E%22">Eberst, L.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ray-Coquard%2C+I%2EL%2E%22">Ray-Coquard, I.L.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verlingue%2C+L%2E%22">Verlingue, L.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cassier%2C+P%2E%22">Cassier, P.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Attignon%2C+V%2EK%2E%22">Attignon, V.K.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chabaud%2C+S%2E%22">Chabaud, S.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mayet%2C+R%2E%22">Mayet, R.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cauquil%2C+E%2E%22">Cauquil, E.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fournier+Garin%2C+G%2E%22">Fournier Garin, G.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Perol%2C+D%2E%22">Perol, D.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blay%2C+J-Y%2E%22">Blay, J-Y.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS291-S292. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189418493 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.648 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S291 Titles: – TitleFull: 216eP MegaMOST - A multicenter, open-label, molecularly selected bayesian phase II platform trial in advanced or metastatic solid tumors: Final analysis of the trametinib cohort. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tredan, O. – PersonEntity: Name: NameFull: Saada, E.B. – PersonEntity: Name: NameFull: Dalban, C. – PersonEntity: Name: NameFull: Cousin, S. – PersonEntity: Name: NameFull: Le Cesne, A. – PersonEntity: Name: NameFull: Italiano, A. – PersonEntity: Name: NameFull: Bertucci, F. – PersonEntity: Name: NameFull: Gomez-Roca, C.A. – PersonEntity: Name: NameFull: Eberst, L. – PersonEntity: Name: NameFull: Ray-Coquard, I.L. – PersonEntity: Name: NameFull: Verlingue, L. – PersonEntity: Name: NameFull: Cassier, P. – PersonEntity: Name: NameFull: Attignon, V.K. – PersonEntity: Name: NameFull: Chabaud, S. – PersonEntity: Name: NameFull: Mayet, R. – PersonEntity: Name: NameFull: Cauquil, E. – PersonEntity: Name: NameFull: Fournier Garin, G. – PersonEntity: Name: NameFull: Perol, D. – PersonEntity: Name: NameFull: Blay, J-Y. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
